N-Cyclopropyl-3-nitrobenzamide is used in pharmaceutical research as an intermediate in the synthesis of biologically active compounds, particularly in the development of kinase inhibitors. It features a 3-nitrobenzamide core with an N-cyclopropyl group, which enhances its utility in medicinal chemistry for targeting specific enzymes involved in inflammatory and oncological pathways. It is also employed in the design of novel amide-based structures to improve metabolic stability and binding affinity in drug candidates.